Called Ghost™, the process creates an integrated, repeating watermark embedded in the composite flexible packaging material making it technically and economically challenging to duplicate. Companies have the flexibility to use corporate logos, brand names or other symbology for the easily visible, overt watermark which provides visual confirmation to the user that the products being used are authentic.
Ghost is ideally suited for chevron pouches used in medical device applications (such as sutures, scalpels, prefilled syringes, artificial joints, catheters, etc.). The technology can also be used in conjunction with blister packs, packets and packaging for other security-driven or luxury items. These include electronic components, collectibles, documents, jewelry, etc.
Rollprint, known for developing many packaging “firsts” for medical device and pharmaceutical applications, created Ghost to give companies a viable, cost-effective anticounterfeiting option. The proprietary technology can be used with a variety of material combinations including peelable and weld seal options used in conjunction with polyester, foil, nylon and other substrates.
“Companies that are currently using anticounterfeiting measures, typically employ covert options that add significant cost and frequently require specialized equipment. Examples include inks only visible under UV light and micro printing. Because the watermark is added concurrently during normal processing, we can usually add the feature at little or no additional cost. It’s just one more example of how Rollprint provides value to its customers,” said Dwane Hahn, vice president of sales and marketing, Rollprint.
Attempting to duplicate the watermark would require very specialized equipment with knowledge of proprietary, advanced technology, coupled with significant financial investment. This makes it a particularly challenging hurdle for counterfeiters to attempt.
“The World Health Organization reports that more than 8 percent of medical devices in circulation are counterfeit and more than 10 percent of global pharmaceutical commerce is counterfeit. These counterfeit devices and drugs not only pose a significant danger to consumer safety but also present a dramatic economic impact to the industry,” said Hahn. “This is why we are pleased to present our proprietary Ghost technology to the marketplace.”